{
  "_originalData": {
    "identity": {
      "bacteriumName": "Aggregatibacter aphrophilus",
      "aliases": [],
      "lastUpdated": "2023-04-12",
      "clsiCategory": "Other Non-Enterobacterales",
      "classification": {
        "gramStain": "Gram-negative",
        "morphology": "Coccobacillus",
        "respiration": "Facultative anaerobe",
        "notes": [
          "Member of the HACEK group of organisms"
        ]
      },
      "strainDetails": [],
      "biochemicalTests": "Gram-negative coccobacillus, facultative anaerobe, catalase –, oxidase –, does not require X or V factors, ferments glucose, maltose, sucrose, and lactose."
    },
    "clinicalProfile": {
      "summary": "Aggregatibacter aphrophilus is a fastidious gram-negative coccobacillus and a member of the HACEK group. It is a rare cause of infective endocarditis and can also cause other infections such as sinusitis, brain abscesses, and osteomyelitis.",
      "pathophysiologyPearls": [
        "Colonizes the human respiratory tract.",
        "Can cause endocarditis on both native and prosthetic valves.",
        "Infections often occur in patients with underlying cardiac conditions or other comorbidities."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Heart murmur",
        "Embolic phenomena",
        "Symptoms related to the site of infection (e.g., headache, focal neurological deficits)"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Infective Endocarditis",
          "description": "A rare but important cause of culture-negative or slow-growing endocarditis."
        },
        {
          "syndromeName": "Brain Abscess",
          "description": "Can occur, often in association with endocarditis or sinusitis."
        },
        {
          "syndromeName": "Osteomyelitis",
          "description": "Has been reported as a rare manifestation."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Patients with pre-existing valvular heart disease",
        "Immunocompromised patients"
      ],
      "transmissionVectors": [
        "Endogenous flora"
      ],
      "prognosisNotes": []
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [],
      "clinicalAlerts": []
    },
    "treatment": {
      "generalNotes": [
        "Treatment recommendations are largely based on case series and expert opinion due to the rarity of infections.",
        "Ceftriaxone is generally the drug of choice.",
        "Consultation with an infectious diseases specialist is recommended."
      ],
      "drugsToAvoid": [],
      "adjunctiveTherapies": [],
      "regimens": [
        {
          "context": {
            "type": "Directed",
            "condition": "Infective Endocarditis",
            "patientPopulation": [
              "Adults"
            ],
            "isolateSource": "Blood"
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "4 weeks (native valve) or 6 weeks (prosthetic valve)",
                  "drugs": [
                    {
                      "drugName": "Ceftriaxone",
                      "dose": "2",
                      "route": "IV",
                      "frequency": "daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Blood cultures should be held for an extended period (at least 2 weeks) if HACEK organisms are suspected."
      ],
      "methodologyNotes": [
        "Grows slowly on standard culture media."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "",
        "biosafetyWarning": "",
        "methods": []
      },
      "preventionAndScreening": [],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [],
      "drugSpecificPearls": [],
      "guidelineReferences": []
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.323Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Aggregatibacter aphrophilus"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": []
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2023-04-12"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-negative",
        "morphology": "Coccobacillus",
        "respiration": "Facultative anaerobe",
        "notes": [
          "Member of the HACEK group of organisms"
        ]
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Aggregatibacter aphrophilus is a fastidious gram-negative coccobacillus and a member of the HACEK group. It is a rare cause of infective endocarditis and can also cause other infections such as sinusitis, brain abscesses, and osteomyelitis.",
      "pathophysiologyPearls": [
        "Colonizes the human respiratory tract.",
        "Can cause endocarditis on both native and prosthetic valves.",
        "Infections often occur in patients with underlying cardiac conditions or other comorbidities."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Heart murmur",
        "Embolic phenomena",
        "Symptoms related to the site of infection (e.g., headache, focal neurological deficits)"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Infective Endocarditis",
          "description": "A rare but important cause of culture-negative or slow-growing endocarditis."
        },
        {
          "syndromeName": "Brain Abscess",
          "description": "Can occur, often in association with endocarditis or sinusitis."
        },
        {
          "syndromeName": "Osteomyelitis",
          "description": "Has been reported as a rare manifestation."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Patients with pre-existing valvular heart disease",
        "Immunocompromised patients"
      ],
      "transmissionVectors": [
        "Endogenous flora"
      ],
      "prognosisNotes": []
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [],
      "clinicalAlerts": []
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Infective Endocarditis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": "Blood"
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Ceftriaxone",
              "dose": "2",
              "route": "IV",
              "frequency": "daily",
              "duration": "4 weeks (native valve) or 6 weeks (prosthetic valve)",
              "comments": "",
              "originalText": "Ceftriaxone 2 IV daily"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Blood cultures should be held for an extended period (at least 2 weeks) if HACEK organisms are suspected."
      ],
      "methodologyNotes": [
        "Grows slowly on standard culture media."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}